- 全部删除
- 您的购物车当前为空
Pinatuzumab是一种靶向CD22的人源化单克隆抗体,常用于合成ADC分子Pinatuzumab vedotin,可用于研究非霍奇金淋巴瘤(NHL)和慢性淋巴细胞白血病(CLL)等B细胞恶性肿瘤。
为众多的药物研发团队赋能,
让新药发现更简单!
Pinatuzumab是一种靶向CD22的人源化单克隆抗体,常用于合成ADC分子Pinatuzumab vedotin,可用于研究非霍奇金淋巴瘤(NHL)和慢性淋巴细胞白血病(CLL)等B细胞恶性肿瘤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,480 | In stock | |
5 mg | ¥ 7,460 | In stock | |
10 mg | ¥ 9,860 | In stock | |
25 mg | ¥ 14,900 | In stock | |
50 mg | ¥ 19,700 | In stock |
Pinatuzumab 相关产品
产品描述 | Pinatuzumab is a humanised monoclonal antibody targeting CD22, commonly used to synthesise the ADC molecule Pinatuzumab vedotin, which is employed in the study of B-cell malignancies such as non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukaemia (CLL). |
别名 | 匹那妥珠单抗 |
CAS No. | 1639820-81-7 |
颜色 | Transparent |
物理性状 | Liquid |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容